Wang Lingke sold $4.5M of LIFE
Wang Lingke (President) sold 118,333 shares of Ethos Technologies Inc. (LIFE) at an average of $38.36 ($37.64–$39.14, $4.54M total) across 3 trades on 2026-10-15 under a Rule 10b5-1 trading plan.
Ethos Technologies Inc.
No enriched coverage for $LIFE in the last 7 days.
Wang Lingke (President) sold 118,333 shares of Ethos Technologies Inc. (LIFE) at an average of $38.36 ($37.64–$39.14, $4.54M total) across 3 trades on 2026-10-15 under a Rule 10b5-1 trading plan.
Colis Peter George (CEO and Secretary) sold 120,000 shares of Ethos Technologies Inc. (LIFE) at an average of $38.39 ($37.64–$39.58, $4.61M total) across 7 trades over 2026-10-14 to 2026-10-16 under a Rule 10b5-1 trading plan.
Ethos Technologies Inc. (NASDAQ: LIFE) will release its Q3 2026 financial results on Nov. 2, 2026, after market close. A conference call is scheduled for 4:30 p.m. ET the same day to discuss the results, with a webcast available on the company's Investor Relations website.
Recent LIFE coverage spans insider activity, financial news and earnings.
In the last 30 days, LIFE insiders filed 10 SEC Form 4 transactions — no purchases and 10 sales ($9.1M). The most active reporter was Colis Peter George, CEO and Secretary, with 7 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
Insider sale may signal negative sentiment, potentially pressuring the stock.
The insider sale may signal confidence concerns and could pressure the stock lower.
The announcement sets the date for the earnings release; no immediate price direction is implied.
Analyst upgrades suggest continued upside potential.
Neutral impact; ownership disclosure may cause modest price pressure as investors assess index eligibility.
AlphAI scores every news story that mentions LIFE with an AI model for sentiment and relevance, and aggregates insider trades from Ethos Technologies Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Wang Lingke (President) sold 118,333 shares of Ethos Technologies Inc. (LIFE) at an average of $38.36 ($37.64–$39.14, $4.54M total) across 3 trades on 2026-10-15 under a Rule 10b5-1 trading plan.
1 min readColis Peter George (CEO and Secretary) sold 120,000 shares of Ethos Technologies Inc. (LIFE) at an average of $38.39 ($37.64–$39.58, $4.61M total) across 7 trades over 2026-10-14 to 2026-10-16 under a Rule 10b5-1 trading plan.
1 min readEthos Technologies Inc. (NASDAQ: LIFE) will release its Q3 2026 financial results on Nov. 2, 2026, after market close. A conference call is scheduled for 4:30 p.m. ET the same day to discuss the results, with a webcast available on the company's Investor Relations website.
1 min readCitizens raised its price target for Ethos Technologies (NASDAQ: LIFE) to $40.00 from $33.00, citing light domestic catastrophe losses and strong revenue growth. The stock has gained 167% over the past six months. Analysts predict profitability this year, supported by 83% sales growth and $190 million in Q2 2026 revenue, exceeding estimates.
1 min readEthos Technologies Inc. (LIFE) filed an SEC Form 8-K — Other Events. Item 8.01. Other Events. Ethos Technologies Inc. (the “Company”) is providing the below beneficial ownership table to provide updated information regarding the beneficial ownership of shares of the Company’s Class A common stock, $0.0001 par value (the “Class A common stock”) and
1 min readAnalysts downgraded several stocks: BTIG cut Liquidia (LQDA) to Neutral, BMO reduced Sigma Lithium (SGML) to Market Perform with a $10 target, Wells Fargo downgraded ExxonMobil (XOM) to Equal-Weight with a $182 target, UBS lowered Ormat (ORA) to Neutral with a $100 target, and JP Morgan changed Ethos (LIFE) to Neutral. Prices as of Wednesday's close: LQDA $30.26, SGML $9.40, XOM $162.75, ORA $91.49, LIFE $33.57.
2 min readWall Street analysts issued updates on various companies. BP (NYSE: BP) was upgraded to Overweight with a $71 target, Dollar Tree (NASDAQ: DLTR) to Buy with a $140 target, and Occidental Petroleum (NYSE: OXY) to Buy with a $69 target. Exxon Mobil (NYSE: XOM) was downgraded to Equal Weight with an $182 target. Other notable initiations and changes include Lennar (NYSE: LEN), Rocket Lab (NASDAQ: RKLB), Teva Pharmaceuticals (NASDAQ: TEVA), and more.
3 min readJPMorgan downgraded Ethos Technologies from Overweight to Neutral, setting a price target of $37. The stock has a 5-day change of -0.83% and a 1st Jan change of -1.00%.
1 min readWang Lingke (President) sold 118,333 shares of Ethos Technologies Inc. (LIFE) at an average of $38.96 ($38.36–$39.67, $4.61M total) across 3 trades on 2026-09-17 under a Rule 10b5-1 trading plan.
1 min readColis Peter George (CEO and Secretary) sold 70,000 shares of Ethos Technologies Inc. (LIFE) at an average of $38.51 ($35.98–$40.35, $2.70M total) across 8 trades over 2026-09-16 to 2026-09-18 under a Rule 10b5-1 trading plan.
1 min read